Indo US Bio-Tech Ltd (INDOUS) is currently trading at 64.53 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Indo US Bio‑Tech Limited is a vertically integrated seed company focused on breeding, production, processing, packing and marketing of hybrid and open‑pollinated agricultural, vegetable, oilseed and spice seeds, operating R&D, seed processing plants and cold storage facilities based largely in Gujarat and selling through a nationwide distributor network. The company highlights a DSIR‑recognised in‑house R&D unit and an internal laboratory that performs ELISA testing; Indo US Bio‑Tech Limited claims a germplasm repository of roughly 4,460 varieties and uses this intellectual and biological asset to develop and commercialize new seed varieties across multiple crop segments. Indo US Bio‑Tech Limited reports board approval of unaudited quarterly financial results for the quarter ended 30 June 2026 with a limited review report that expressed an unmodified opinion, indicating compliance with interim reporting requirements and auditor scrutiny for those financials as disclosed in the investor presentation. Operationally, Indo US Bio‑Tech Limited combines owned processing facilities, cold storage capacity of about 18,000 sq. ft. with 1,500 tonne storage capability, and hired custom processing to meet seasonal demand, supported by a distribution network exceeding 2,500 dealers and distributors to enable timely seed supply across regions.

Over the past 52 weeks, Indo US Bio-Tech Ltd has traded between a low of ₹60.00 and a high of ₹158.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Indo US Bio-Tech Ltd has a market capitalization of approximately 132.92. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Indo US Bio-Tech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 30.63 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 132.92 Cr, Indo US Bio-Tech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Indo US Bio-Tech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Indo US Bio-Tech Ltd is 30.63. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.